A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.
about
Plasma transfusions prior to insertion of central lines for patients with abnormal coagulationPlasma transfusion strategies for critically ill patientsPlasma transfusion strategies for critically ill patientsIs solvent/detergent plasma better than standard fresh-frozen plasma? A systematic review and an expert consensus documentProphylactic plasma and platelet transfusion in the critically Ill patient: just useless and expensive or even harmful?Evidence and triggers for the transfusion of blood and blood productsHaemostatic management of cardiac surgical haemorrhageA 2014 Update on Coagulation Management for Cardiopulmonary Bypass.Thrombocytopenia and platelet transfusion in UK critical care: a multicenter observational study.Transfusion of fresh-frozen plasma in critically ill patients with a coagulopathy before invasive procedures: a randomized clinical trial (CME).The management of abnormal haemostasis in the ICU.Monitoring and Treatment of Coagulation Disorders in End-Stage Liver Disease.Is fresh-frozen plasma clinically effective? An update of a systematic review of randomized controlled trials.Plasma is ineffective in correcting mildly elevated PT-INR in critically ill children: a retrospective observational studyThe fibrinogen but not the Factor VIII content of transfused plasma determines its effectiveness at reducing bleeding in coagulopathic mice.The conundrum of persistent inappropriate use of frozen plasma.Successful implementation of a packed red blood cell and fresh frozen plasma transfusion protocol in the surgical intensive care unitTransfusion of fresh frozen plasma in non-bleeding ICU patients--TOPIC trial: study protocol for a randomized controlled trial.Transfusion Patterns in All Patients Admitted to the Intensive Care Unit and in Those Who Die in Hospital: A Descriptive Analysis.Adverse effects of plasma transfusionPlasma transfusions prior to insertion of central lines for people with abnormal coagulation.Prophylactic plasma transfusion for surgical patients with abnormal preoperative coagulation tests: a single-institution propensity-adjusted cohort study.Outcomes of patients with rodenticide poisoning at a far east poison center.Severe sepsis and septic shock: management and performance improvement.Plasma transfusion for bedside, radiologically guided, and operating room invasive procedures.Controversies in the use of fresh frozen plasma in critically ill small animal patients.Risk of Procedural Hemorrhage.Image-guided intervention in the coagulopathic patient.Factors influencing plasma transfusion practices in paediatric intensive care units around the world.Evaluation of a multi-center randomised clinical trial on prophylactic transfusion of fresh frozen plasma: implications for future trials.Prophylactic Plasma Transfusion Is Not Associated With Decreased Red Blood Cell Requirements in Critically Ill Patients.How we manage AB plasma inventory in the blood center and transfusion service.Changing trends in blood transfusion: an analysis of 244,013 hospitalizations.Association between plasma transfusions and clinical outcome in critically ill children: a prospective observational study.The effect of fresh frozen plasma in critically ill patients.Plasma transfusions prior to lumbar punctures and epidural catheters for people with abnormal coagulation.Solvent detergent vs. fresh frozen plasma in cirrhotic patients undergoing liver transplant surgery: a prospective randomized control study.Changes in colloid solution sales in Nordic countries.Prediction of bleeding and thrombosis by standard biochemical coagulation variables in haematological intensive care patients.Prophylactic plasma transfusion for patients undergoing non-cardiac surgery.
P2860
Q24187500-A3B8CE85-0B6C-4020-847D-4734C1E550F9Q24201589-28478643-43EF-49B6-BF0E-8E7EA1ADA477Q24201609-4A4FE1F2-0B60-4336-BA25-D8B84A217C3AQ26748355-3CA05167-20E1-4ADE-92C2-975F055343CDQ27001075-DED83AD9-2277-4AEE-B36B-12180FD0EEE8Q27008573-13AF67B4-4D71-4044-938E-C13F32E3299DQ27024386-1C762149-2F8A-4BB2-A5D6-7A6EEFC5F563Q30458252-69CE2384-28AB-45DC-8CE7-583CBA214A09Q33403000-5FD4499F-BAA8-477F-821F-480131512F73Q33415825-79C2D8E3-391F-429A-A836-753044BCBB75Q33418970-D8058220-6DED-49B4-8A4A-7DEDC0DFCF1DQ33435884-22F546C1-029B-4273-8877-68B0DE760181Q34132303-1D31128D-0586-4891-9FF3-21C9FDBEF0B5Q35106675-3B26AE79-1A06-472A-8CFA-1A32643FC8B5Q35430725-644354E4-7741-40F0-892D-DD7DBB7D7CC8Q35558167-0631E202-A9C6-40FC-8991-CDD0382E0469Q35641141-466A495A-8685-41C9-A34C-A87C6CC031C1Q35772078-C8DCAAFD-E92E-490F-A5B9-04CC379A7418Q35778313-113526CE-C1D5-4648-BCAB-14B17DC7767BQ35972184-5A98FBFC-229A-47E1-AD81-6AFF415EF97DQ36137840-5861DEE0-C368-43D4-9B25-3E46D61DE78AQ36760558-C74509C2-F04E-443D-97EF-7B1F29111807Q37226004-DFF0CF95-A3DF-45AE-AD39-6DCF92B01F0BQ37562996-94EC82BB-ECD4-45F0-9C1C-B1D157929D31Q38009414-0674650E-2062-4387-82C5-A027F70622D5Q38325203-6E3D39FD-96F1-4975-8B49-B5658DE9EAD6Q38719988-6DAE5346-1E9B-4A98-A44A-90A3D7A975A5Q38750017-48F7DA68-EF08-43EB-90DC-946CCB782DCDQ38972866-0690C62A-8E82-41AA-97CE-52CB8C91CBDDQ39132227-991536A7-C4F0-4164-8F72-63477898C3EBQ40342989-15B5BCD5-2683-411C-99F4-DEE6B36EE48DQ43659698-210DEB89-1B12-4B98-8F0B-47C4E98DFC41Q44337668-204F837F-FCAA-41F4-97AD-8A1F2F6AD78CQ44378745-C2AB30F5-61D3-4A66-8DF9-9450467201BDQ45866452-912A175B-B3E4-4530-A259-5D1DF2CB68CAQ45872457-9E6AA30F-EE95-4AD8-82D7-0B6E61AD102CQ46734739-11D71B2E-04AA-4962-AE52-789CDCC6FB40Q47190025-2735348A-1DA4-48F4-B116-9F4CFDCD4CD2Q47220914-7330EED4-09CF-4A8D-8981-24BC81D457E8Q47229511-4F05B43E-5E7D-4C5B-AC2B-B4321D9508BB
P2860
A national study of plasma use in critical care: clinical indications, dose and effect on prothrombin time.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
A national study of plasma use ...... nd effect on prothrombin time.
@ast
A national study of plasma use ...... nd effect on prothrombin time.
@en
type
label
A national study of plasma use ...... nd effect on prothrombin time.
@ast
A national study of plasma use ...... nd effect on prothrombin time.
@en
prefLabel
A national study of plasma use ...... nd effect on prothrombin time.
@ast
A national study of plasma use ...... nd effect on prothrombin time.
@en
P2093
P2860
P356
P1433
P1476
A national study of plasma use ...... nd effect on prothrombin time.
@en
P2093
Douglas M Watson
Duncan Wyncoll
Intensive Care Study of Coagulopathy (ISOC) investigators
Robert J Lee
Robin J Prescott
Simon J Stanworth
Timothy S Walsh
P2860
P2888
P356
10.1186/CC10129
P577
2011-04-05T00:00:00Z
P5875
P6179
1030030100